Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population

Table 5 Comparisons of the frequencies of overall and nocturnal hypoglycemia (glucose< 70 mg/dl) events recorded on CGMS over 3 days when using Insulin Glargine and Insulin Degludec

		0 weeks	26 weeks	P
1	Total Hypoglycemia	1.92 ± 1.26	0.35 ± 0.49	0.0026*
2	Nocturnal Hypoglycemia	0.92 ± 0.47	0.21 ± 0.42	0.0021*

ISSN: 1687-9856